Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Filings indexed 453 across all filing types
Latest filing 2024-01-08 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended December 31, 2023. It is addressed to stock exchanges and signed by the company secretary and compliance officer. The content is a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. The document length is short (3538 characters) and it is primarily a regulatory compliance confirmation. Therefore, it fits the category of Regulatory Filings (RNS), which covers officer certifications and compliance documents that do not constitute full financial reports.
2024-01-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) informing about the closure of the trading window pursuant to SEBI regulations related to insider trading. It specifies the trading window closure period around the upcoming financial results announcement for the quarter ended December 31, 2023. The document does not contain any financial data, results, or detailed report content. It is an announcement related to compliance and trading restrictions rather than a financial report or earnings release. The document length is short (2227 characters), and it serves as a regulatory notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance-related announcements that do not fit other specific categories.
2023-12-27 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding a non-compliance issue with SEBI Listing Regulations, specifically Regulation 17(1). It details the Board of Directors' meeting where the matter was discussed, the fine levied by the exchanges, and the payment of the fine. The document is an intimation or announcement about regulatory compliance and actions taken, not a financial report or detailed audit. It does not contain financial statements, earnings data, or detailed management discussion. It is a regulatory announcement about compliance and fine payment, fitting best under Regulatory Filings (RNS). The document length is 4508 characters, which is relatively short and consistent with a regulatory announcement rather than a full report.
2023-11-03 English
Copy of Newspaper Publication
Regulatory Filings
2023-11-03 English
Financial Result Updates
Regulatory Filings
2023-11-02 English
Updates
Regulatory Filings
2023-10-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.